Company / Capital Expenditures
Exelixis Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$8.4M
FY2025
5-year range
$8.4M / $40.5M
FY2021-FY2025
Trend
-70.4%
vs FY2024
Sector context
#63 of 194
Health Care
What the data says
At $8M, Exelixis's capital expenditures ranks #63 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $2M in FY2018 to $40M in FY2023.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of -22.6%.
Declined from $40M to $8M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -34.8%
- 5-Year CAGR
- -22.6%
- 10-Year CAGR
- -
Sector benchmark
#63 of 194 in Health CareTop 32% of 194This company $8.4M Sector average $117.5M
▼
-92.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -22.6%, indicating a declining trend.
- In FY2025, capital expenditures decreased 70.4% year-over-year.
- Ranks #63 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.4M | -70.4% |
| FY2024 | $28.4M | -29.7% |
| FY2023 | $40.5M | +33.4% |
| FY2022 | $30.3M | +136.4% |
| FY2021 | $12.8M | -57.7% |
| FY2020 | $30.3M | +136.4% |
| FY2019 | $12.8M | +653.6% |
| FY2018 | $1.7M | -91.9% |
| FY2017 | $21.1M | +1141.5% |
| FY2016 | $1.7M | +281.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026